Prediction of Rebound Hyperbilirubinemia

Abstract

Research Article| November 01 2019 Prediction of Rebound Hyperbilirubinemia AAP Grand Rounds (2019) 42 (5): 51. https://doi.org/10.1542/gr.42-5-51 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Share Icon Share Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Prediction of Rebound Hyperbilirubinemia. AAP Grand Rounds November 2019; 42 (5): 51. https://doi.org/10.1542/gr.42-5-51 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All AAP SitesAll PublicationsAll JournalsAAP Grand RoundsPediatricsHospital PediatricsPediatrics In ReviewNeoReviewsAAP News Search Advanced Search Topics: hyperbilirubinemia, phototherapy Source: Chang PW, Newman TB. A simpler prediction rule for rebound hyperbilirubinemia. Pediatrics. 2019; 144(1):pii: e20183712; doi: https://doi.org/10.1542/peds.2018-3712Google Scholar Investigators from Seattle Children’s Hospital and the University of California, San Francisco, conducted a retrospective analysis to develop a 2-variable clinical prediction rule to quantify the risk of rebound hyperbilirubinemia in newborns who undergo phototherapy. The prediction rule included a newborn’s gestational age and the difference between the AAP-recommended threshold total serum bilirubin (TSB) level at the time that phototherapy was initiated and the TSB level at the time that phototherapy was discontinued (TSB difference).1 To develop the prediction rule, the authors abstracted medical record data in newborns born at ≥35 weeks’ gestation at Kaiser Permanente Northern California hospitals between 2012 and 2014 who underwent inpatient phototherapy. The study sample was randomly divided into a derivation sample to develop the... 2019 You do not currently have access to this content.